AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma

Title
AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 218, Issue 9, Pages -
Publisher
Rockefeller University Press
Online
2021-07-30
DOI
10.1084/jem.20200962

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started